Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant

被引：0
|
作者：
Kitko, Carrie L. [1 ]
Braun, Thomas [2 ]
Schuler, Charles [3 ]
Choi, Sung Won [1 ]
Yanik, Gregory [1 ]
Pawarode, Attaphol [4 ]
Magenau, John [4 ]
Taylor, Austin [5 ]
Ferrara, James L. M. [5 ]
Couriel, Daniel R. [4 ]
Levine, John [1 ]
机构：
[1] Univ Michigan, Pediat Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Adult Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
490
引用
收藏
页码：S337 / S337
页数：1
相关论文
共 50 条
  • [1] Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial
    Kitko, Carrie L.
    Braun, Thomas
    Couriel, Daniel R.
    Choi, Sung W.
    Connelly, James
    Hoffmann, Sandra
    Goldstein, Steven
    Magenau, John
    Pawarode, Attaphol
    Reddy, Pavan
    Schuler, Charles
    Yanik, Gregory A.
    Ferrara, James L.
    Levine, John E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 862 - 868
  • [2] Reduced intensity conditioning unrelated transplant plus cyclosporine and MMF as GVHD prophylaxis: Results of a prospective study.
    Perez-Simon, JA
    Martino, R
    de la Camara, R
    de Oteiza, JP
    Moraleda, JM
    Diez-Campelo, M
    Sureda, A
    Alegre, A
    Sierra, J
    San Miguel, JF
    BLOOD, 2005, 106 (11) : 413B - 413B
  • [3] Peri-transplant extracorporeal photopheresis to mitigate GVHD- a pilot clinical trial
    Haitham Abdelhakim
    Anthony Accurso
    Dean Merkel
    Shaun Dejarnette
    Omar Aljitawi
    Thomas Yankee
    Jianghua He
    Siddhartha Ganguly
    Joseph McGuirk
    Sunil Abhyankar
    Bone Marrow Transplantation, 2021, 56 : 980 - 982
  • [4] Peri-transplant extracorporeal photopheresis to mitigate GVHD- a pilot clinical trial
    Abdelhakim, Haitham
    Accurso, Anthony
    Merkel, Dean
    Dejarnette, Shaun
    Aljitawi, Omar
    Yankee, Thomas
    He, Jianghua
    Ganguly, Siddhartha
    McGuirk, Joseph
    Abhyankar, Sunil
    BONE MARROW TRANSPLANTATION, 2021, 56 (04) : 980 - 982
  • [5] Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study
    Michallet, Mauricette
    Sobh, Mohamad
    Garban, Frederic
    Bulabois, Claude Eric
    Yakoub-Agha, Ibrahim
    Coiteux, Valerie
    Dulery, Remy
    Rohrlich, Pierre-Simon
    Legrand, Faezeh
    Clement, Laurence
    Praire, Aline
    Detrait, Marie
    Barraco, Fiorenza
    Nicolini, Franck Emmanuel
    Hequet, Olivier
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 372 - 380
  • [6] Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis
    Modi, Dipenkumar
    Singh, Vijendra
    Kim, Seongho
    Ayash, Lois
    Deol, Abhinav
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 969 - 978
  • [7] Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis
    Dipenkumar Modi
    Vijendra Singh
    Seongho Kim
    Lois Ayash
    Abhinav Deol
    Voravit Ratanatharathorn
    Joseph P. Uberti
    Annals of Hematology, 2021, 100 : 969 - 978
  • [8] A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
    Khaled, S. K.
    Palmer, J.
    Stiller, T.
    Senitzer, D.
    Maegawa, R.
    Rodriguez, R.
    Parker, P. M.
    Nademanee, A.
    Cai, J-L
    Snyder, D. S.
    Karanes, C.
    Osorio, E.
    Thomas, S. H.
    Forman, S. J.
    Nakamura, R.
    BONE MARROW TRANSPLANTATION, 2013, 48 (02) : 278 - 283
  • [9] A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
    S K Khaled
    J Palmer
    T Stiller
    D Senitzer
    R Maegawa
    R Rodriguez
    P M Parker
    A Nademanee
    J-L Cai
    D S Snyder
    C Karanes
    E Osorio
    S H Thomas
    S J Forman
    R Nakamura
    Bone Marrow Transplantation, 2013, 48 : 278 - 283
  • [10] Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD
    Rodriguez, R.
    Nademanee, A.
    Palmer, J. M.
    Parker, P.
    Nakamura, R.
    Snyder, D.
    Pullarkat, V.
    Zain, J.
    Smith, E.
    Sahebi, F.
    Patane, K.
    Senitzer, D.
    Chang, K.
    Forman, S. J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (01) : 205 - 207
12345